卖什么
Predictive analytics and clinical pathways for hospitals
商业模式拆解
买家：谁掌握预算？
Hospital and health-system clinical leadership (nurse managers, quality, CMO/CNO); site claims 400+ hospitals and 150,000+ clinical users.
工作流：什么输入变成什么输出？
eCART FDA-cleared AI scores inpatient deterioration risk in real time inside the EHR to prioritize patients and trigger escalation; Clinical Pathways embeds current protocols into order entry and documentation.
经济账：省了什么，怎么收费？
Value claims: each hour of delayed ICU transfer raises mortality odds 3%; timely transfer shortens stay by 2 days; deploys in days to weeks.
渠道：怎么接触到客户？
Demo-led enterprise sales to health systems ("Request Demo", "Get in touch").
融资历史与报道
| 融资日期 | 轮次 | 金额 | 投资方 | 来源 |
|---|---|---|---|---|
| — | YC 2011 夏季 | — | Y Combinator | ycombinator.com |
档案汇总自公开报道和公司官网。商业模式部分是 MaxBC 对这些材料的解读，不是已确认的事实；未知之处留空，不作猜测。 更新于 2026-10-12.